Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.21
+0.03 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
9.40
+0.19 (2.03%)
After-hours: Dec 5, 2025, 7:02 PM EST
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$754,400
Market Cap
29.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PASG News
- 25 days ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 7 weeks ago - Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 3 months ago - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 5 months ago - Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update - GlobeNewsWire
- 7 months ago - Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire